ARTICLE | Company News
ImClone receives $2 million milestone
March 15, 2000 8:00 AM UTC
The milestone in IMCL's IMC-C225 development and commercialization agreement with Merck KGaA (Darmstadt, Germany) relates to the expansion into France of Merck's Phase II study of IMC-C225 antibody an...